Human Tau Transgenic Mice

[1]  R. Nitsch,et al.  In Vivo Analysis of Wild‐type and FTDP‐17 Tau Transgenic Mice , 2000, Annals of the New York Academy of Sciences.

[2]  R. A. Crowther,et al.  Axonopathy and amyotrophy in mice transgenic for human four-repeat tau protein , 2000, Acta Neuropathologica.

[3]  R. Nitsch,et al.  Distinct role of protein phosphatase 2A subunit Cα in the regulation of E-cadherin and β-catenin during development , 2000, Mechanisms of Development.

[4]  R. Nitsch,et al.  In vivo analysis of wild-type and FTDP-17 tau mutant mice , 2000, Neurobiology of Aging.

[5]  M. Goedert,et al.  Tau gene mutations in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17) , 2000, Neurogenetics.

[6]  N. Hirokawa,et al.  Muscle weakness, hyperactivity, and impairment in fear conditioning in tau-deficient mice , 2000, Neuroscience Letters.

[7]  H. Geerts,et al.  Prominent axonopathy in the brain and spinal cord of transgenic mice overexpressing four-repeat human tau protein. , 1999, The American journal of pathology.

[8]  Bin Zhang,et al.  Age-Dependent Emergence and Progression of a Tauopathy in Transgenic Mice Overexpressing the Shortest Human Tau Isoform , 1999, Neuron.

[9]  T. Komori,et al.  Tau‐positive dial Inclusions in Progressive Supranuclear Palsy, Corticobasal Degeneration and Pick's Disease , 1999, Brain pathology.

[10]  D. Lomas,et al.  Familial dementia caused by polymerization of mutant neuroserpin , 1999, Nature.

[11]  J. Götz,et al.  The Role of Protein Phosphatase 2A Catalytic Subunit Cα in Embryogenesis: Evidence from Sequence Analysis and Localization Studies , 1999, Biological chemistry.

[12]  E. Mandelkow,et al.  Tau regulates the attachment/detachment but not the speed of motors in microtubule-dependent transport of single vesicles and organelles. , 1999, Journal of cell science.

[13]  Olivier Rascol,et al.  A mutation at codon 279 (N279K) in exon 10 of the Tau gene causes a tauopathy with dementia and supranuclear palsy , 1999, Acta Neuropathologica.

[14]  B. Hemmings,et al.  Delayed embryonic lethality in mice lacking protein phosphatase 2A catalytic subunit Calpha. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[15]  Ronald C. Petersen,et al.  Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17 , 1998, Nature.

[16]  Masato Hasegawa,et al.  Alzheimer-like Changes in Microtubule-associated Protein Tau Induced by Sulfated Glycosaminoglycans , 1997, The Journal of Biological Chemistry.

[17]  B. Sommer,et al.  Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[18]  Guy A. Rouleau,et al.  SOD1 mutation is assosiated with accumulation of neurofilaments in amyotrophic lateral scelaries , 1996 .

[19]  D. Schatz,et al.  A modified tetracycline-regulated system provides autoregulatory, inducible gene expression in cultured cells and transgenic mice. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[20]  P. Cohen,et al.  Molecular dissection of the paired helical filament , 1995, Neurobiology of Aging.

[21]  H. Braak,et al.  Staging of alzheimer's disease-related neurofibrillary changes , 1995, Neurobiology of Aging.

[22]  M. Goedert,et al.  Somatodendritic localization and hyperphosphorylation of tau protein in transgenic mice expressing the longest human brain tau isoform. , 1995, The EMBO journal.

[23]  G. Bloom,et al.  A novel pool of protein phosphatase 2A is associated with microtubules and is regulated during the cell cycle , 1995, The Journal of cell biology.

[24]  N. Hirokawa,et al.  Altered microtubule organization in small-calibre axons of mice lacking tau protein , 1994, Nature.

[25]  M. Goedert,et al.  Expression of separate isoforms of human tau protein: correlation with the tau pattern in brain and effects on tubulin polymerization. , 1990, The EMBO journal.

[26]  J. Brion,et al.  Transgenic expression of the shortest human tau affects its compartmentalization and its phosphorylation as in the pretangle stage of Alzheimer's disease. , 1999, The American journal of pathology.

[27]  F. Gallyas,et al.  Silver staining of Alzheimer's neurofibrillary changes by means of physical development. , 1971, Acta morphologica Academiae Scientiarum Hungaricae.